Beverly A. Mock - Concepedia

Author

Beverly A. Mock

Also Known As

B A Mock, B Mock, B. A. Mock, B. Mock, B.A. Mock, BEVERLY A. MOCK, Beverly A . Mock, Beverly A Mock, Beverly A. Mock, Beverly Mock

168

Publications

5.9K

Citations

H-Index

115

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institute of Allergy and Infectious Diseases Cancer Genetics (United States)

About

Beverly A. Mock is an author at National Cancer Institute specializing in medicine, cell biology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	43	2.4K
2	Natural Sciences	5	5	282
3	Health Sciences	3	3	116
4	Allergy	3	3	471
5	Biochemistry	1	1	30

Beverly A. Mock

Publications

Citations

H-Index

Page 1

	Year	Citations
Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression Jinming Wu, Jie Liu, Edmund B. Chen, Cell Reports	2013	331
Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. Roberto Patarca, Gordon J. Freeman, R. P. Singh, The Journal of Experimental Medicine Functional StudiesMicrobial PathogensAdaptive Immune SystemImmunologyRickettsiology	1989	319
Interleukin 6 is essential for in vivo development of B lineage neoplasms. David M. Hilbert, Manfred Köpf, Beverly A. Mock, The Journal of Experimental Medicine Lymphocyte DevelopmentImmunologyPathologyImmunologic MechanismImmune System	1995	227
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex David Calabrese, Xiang Chen, Elena C. Leon, Nature Communications	2018	166
<i>Cdkn2a</i>, the cyclin-dependent kinase inhibitor encoding p16<sup>INK4a</sup>and p19<sup>ARF</sup>, is a candidate for the plasmacytoma susceptibility locus,<i>Pctr1</i> Shuling Zhang, Edward S. Ramsay, Beverly A. Mock Proceedings of the National Academy of Sciences GeneticsImmunologyPathologyCancer BiologyTumor Biology	1998	149
Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression Kenneth M. Felsenstein, Lindsey B. Saunders, John K. Simmons, ACS Chemical Biology Molecular BiologyCancer BiologyGene Expression ProfilingTumor BiologyTranscriptional Regulation	2015	125
Molecular genetic markers spanning mouse chromosome 10 Christine A. Kozak, M. Peyser, Marianne Krall, Genomics CytogeneticsGeneticsMolecular Genetic MarkersChromosome BiologyMolecular Genetics	1990	121
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production Shuling Zhang, Julie A. Readinger, Wendy Dubois, Blood	2010	121
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression Z Liu, Xinyun Yang, Z Li, Cell Death and Differentiation Candidate Tumor-suppressor GeneMedicineGene ExpressionNeuroblastoma Tumor GrowthTumor Suppressor	2011	97
Hormonal modulation of sex differences in resistance to Leishmania major systemic infections Beverly A. Mock, Carol A. Nacy Infection and Immunity Parasitic DiseaseTestosterone TreatmentAllergyF1 HybridsParasitic Protozoa	1988	93

Page 1